WINDY 200 mg/5 mg — Mucolytic Oral Granules

Pack size: 10 sachets • Sachet weight: 5 g each • Oral granules

Important composition note: The product name provided lists “200 mg/5 mg” alongside acetylcysteine. Acetylcysteine 200 mg is a recognized mucolytic strength, but the identity of the additional 5 mg ingredient should be confirmed from the WINDY package or leaflet before assigning it a role or describing its effects.

Medical Description

WINDY Mucolytic Oral Granules are intended to help relieve chest congestion associated with thick, sticky bronchial secretions. Acetylcysteine is a mucolytic agent that reduces the viscosity of mucus, making phlegm easier to cough up and helping facilitate airway clearance.

It may be used as an adjunct in respiratory conditions associated with excessive or tenacious mucus production, including selected cases of acute bronchitis and other respiratory disorders, according to the approved product information.

Indications and Potential Benefits

• Thick bronchial mucus: Helps loosen and thin sticky respiratory secretions.
• Productive cough: Facilitates the removal of phlegm by coughing.
• Chest congestion: May help relieve mucus-related congestion in selected respiratory conditions.
• Bronchitis-associated secretions: May support mucus clearance during episodes of bronchitis when clinically appropriate.

WINDY is a mucolytic product; it does not directly treat the underlying cause of a respiratory infection.

Mechanism of Action

Acetylcysteine contains a free sulfhydryl group that breaks disulfide bonds within mucus glycoproteins. This reduces mucus viscosity and elasticity, making secretions less thick and easier to expel from the respiratory tract.

Dosage and Administration

• Route: Oral.
• Preparation: Dissolve or disperse the granules in the amount of water specified in the package leaflet, if required, and take as directed.
• Dose and frequency: Must be confirmed from the official WINDY product leaflet because the additional 5 mg ingredient has not been identified.
• Hydration: Adequate fluid intake may support the mucus-thinning effect, unless fluid restriction has been medically advised.

Do not assume that dosing instructions for acetylcysteine-only products apply to WINDY if it contains an additional active ingredient.

Contraindications and Precautions

• Do not use in patients with known hypersensitivity to acetylcysteine or any other ingredient.
• Patients with asthma or a history of bronchospasm should seek medical advice before use.
• Use cautiously in patients with a history of peptic ulcer disease.
• Mucolytics should not routinely be combined with cough-suppressant medicines without medical advice, as suppressing the cough reflex may impair the clearance of loosened secretions.
• Age restrictions depend on the complete formulation and approved product labeling.

Seek medical assessment if symptoms worsen, breathing becomes difficult, fever persists, or the cough does not improve.

Possible Side Effects

Potential adverse effects associated with oral acetylcysteine include:

• Nausea and vomiting.
• Abdominal discomfort or diarrhea.
• Hypersensitivity reactions, including rash or itching.
• Rarely, severe allergic reactions or bronchospasm.

Additional adverse effects may occur depending on the unidentified 5 mg ingredient. Seek urgent medical care for facial or throat swelling, severe breathing difficulty, or other signs of a serious allergic reaction.

Drug Interactions

• Antitussives: Cough suppressants may interfere with the removal of loosened mucus.
• Certain antibiotics: Some product leaflets recommend separating administration times; follow the specific product instructions.
• Other medicines: Interactions depend on the complete formulation, particularly the identity of the additional 5 mg ingredient.

Inform your physician or pharmacist about all medicines and supplements being used.

Storage

Store according to the manufacturer's instructions on the package. Keep the sachets in their original packaging, protect them from moisture and excessive heat, and keep them out of reach of children.

References

1. Egyptian Drug Authority (.gov): Egyptian Drug Formulary — Respiratory Medicines, 2026 — acetylcysteine classification, mucolytic indications, and dosing information.

2. U.S. National Library of Medicine (.gov): DailyMed — Acetylcysteine Drug Information — pharmacological action and safety information.

3. Electronic Medicines Compendium (.org.uk): Acetylcysteine 200 mg Powder for Oral Solution — Patient Leaflet — mucolytic action, administration, precautions, and adverse effects.

4. French Public Medicines Database (.gouv.fr): Acetylcysteine 200 mg — Official Product Information — indications, dosage, contraindications, and precautions.

These references support the general information on acetylcysteine and do not confirm the exact composition or approved labeling of WINDY.

Patient Disclaimer

This description is provided for educational and informational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Use WINDY according to its approved package leaflet and the advice of a qualified healthcare professional. The complete active ingredients, appropriate dosage, age restrictions, and contraindications must be verified before use. Consult a physician or pharmacist if symptoms persist or worsen, and seek urgent medical attention for severe breathing difficulties or signs of a serious allergic reaction.